Ces radiol. 2011, 65(3):229-233

Morphological findings in neurolupus patients with symptomatic strokeOriginal article

Věra Peterová1, Miroslav Kron1, Antonie Vojtěchová1, Kamila Peterová1, Ctibor Dostál2, DanaTegzová2, Radka Svobodová2
1 MR oddělení Radiodiagnostické kliniky 1. LF UK a UK, Praha
2 Revmatologická klinika 1. LF UK a UK, Praha

Aim: The aim of the study was to evaluate the findings of magnetic resonance (MR) in patients with neuropsychiatric lupus erythematosus (NPSLE) with symptomatic stroke.

Methods: The cohort of patients was created from 10 NPSLE patients with symptomatic stroke out of total 60 NPSLE patients (9 females, 1 male of the age 20-55 years), which were investigated on spiral CT and 1.5T MR. CT investigation was performed in spiral mode without contrast application. MR investigation included: pre- and post-contrast T1 weighted images (T1WI) with and without magnetization transfer (MT), T2 weighted images (T2WI) and flow attenuated inversion recovery (FLAIR) in axial and sagittal, 3mm and 6mm slices.

Results: In patients with symptomatic strokes three major types of focal abnormalities were seen on the T2WI: 1. wedge-shaped hyperintense corticol-subcortical foci > 6 mm correlated to postmalatic pseudocysts were present in 42.1% of patients; 2. smaller hyperintense multifocal foci < 6 mm with diffuse distribution, predominantly in the subcortical region in frontal and parietal lobes corresponding to microinfarcts, which were present in all NPSLE patients; 3. hyperintense areas > 6 mm diffusely spread in the grey and white matter representing edema were observed in 10.5% of patients. Metabolically active foci hypersignal on T1WI with MT were observed in 37% of patients. The postmalatic lesions in MR were distributed predominantly in the territory of arteria cerebri media (ACM). The blood brain barrier disruption was not present in our patients. Various degree of cerebral atrophy was observed in 57.9% patients.

Conclusion: Strokes were represented in clinical neuropsychiatrical symptomatology in 31.7% of our NPSLE patients. The MRI findings seen in the NPSLE patients with symptomatic stroke did not significantly differ from those seen in NPSLE patients with other clinical neuropsychiatric symptoms. Postmalatic lesions were observed only in 42.1% of our stroke patients, most often in supratentorial regions, usually in vascular borderlands and ACM territory prevailed. Small focal lesions up to 6mm are similar to NPSLE patients with any clinical symptomatology including strokes and 3mm size usually prevails.

Keywords: neuropsychiatric lupus, stroke, magnetic resonance
Grants and funding:

Práce vychází z výzkumných záměrů MZO 00064165 a 000 000 23728.

Accepted: July 15, 2011; Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Peterová V, Kron M, Vojtěchová A, Peterová K, Dostál C, DanaTegzová, Svobodová R. Morphological findings in neurolupus patients with symptomatic stroke. Ces radiol. 2011;65(3):229-233.
Download citation

References

  1. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology 2002; 41: 619-630. Go to original source... Go to PubMed...
  2. Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, Mc Glasson D. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002; 58: 1214-1220. Go to original source... Go to PubMed...
  3. Rivest C, Lew R, Welsing P, et al. Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000; 27: 680-684.
  4. Dostál C, Peterová V, Palečková J, Vencovský J. Cerebral Disease in SLE: selected autoantibodies and major central nervous system disorder. Lupus 1996; 5: 544.
  5. Olejárová M, Dostál C, Peterová V, Adam P, Vencovský J. Anticardiolipin antibodies in sera and CSF of SLE patients with different types of CNS involvement. Lupus 1998; 7(Suppl 2): B092.
  6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277. Go to original source... Go to PubMed...
  7. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Syndromes. Arthritis Rheum 1999; 42: 599-601. Go to original source...
  8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725. Go to original source... Go to PubMed...
  9. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-499. Go to original source... Go to PubMed...
  10. Costallat L, Bertolo M, Appenzeller S. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes: analysis of 527 patients. Lupus 2001; 10: S32. Go to original source...
  11. Hanly JG, McCurdy G, Fougere L, Douglas J-A, Thompson K. Neuropsychiatric events in Systemic Lupus Erythematosus (SLE): attribution and clinical significance. J Rheumatol 2004; 31(11): 2156-2162.
  12. Sanna G, Berolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
  13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640. Go to original source... Go to PubMed...
  14. Sewell KL, Livneh A, Aranow CB, Grayze AI. Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus. Am J Med 1989; 86(5): 625-626. Go to original source... Go to PubMed...
  15. Sibbitt WL Jr, Sibbitt RR, Grifey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erytethematosus. Ann Rheum Dis 1989: 48: 1014-1022. Go to original source... Go to PubMed...
  16. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004; 46(1): 15-21. Go to original source... Go to PubMed...
  17. Rovaris M, Inglese M, Viti B, Ciboddo G, et al. The contribution of fast FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases. J Neurol 2000; 2347: 29-33. Go to original source... Go to PubMed...
  18. Podrazilová L, Peterová V, Olejárová M, et al. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematodes. Clin Exp Rheumat 2008; 26: 604-610.
  19. Peterová V, Dostál C, Seidl Z, Daneš J, Obenberger J, Viták T, Olejárová M. Magnetic resonance of the brain in systemic lupus erythematosus patients with neuropsychiatric symptomatology. Čes Revm 1998; 6: 134-137.
  20. Taccari E, Scavalli AS, Spadaro A, et al. Magnetic resonance imaging (MRI) of the brain in SLE: ECLAM and SLEDAI correlations. Clin Exper Rheum 1994; 12: 23-28.
  21. Sibbitt WL, Schmidt PJ, Blaine LH, Brooks WM. Fluid Attenuated Inversion Recovery (FLAIR) Imaging in Neuropsychiatric Systemic Lupus Erythematosus. J Rheumatol 2003; 30: 1983-1989.
  22. Tourbah A, Deschamps R, Stievenart JL. Magnetic resonance imaging using FLAIR pulse sequence in white matter diseases. J Neuroradiol 1996; 23: 217-222.
  23. Peterová V, Dostál C, Linková L, et al. The distribution of MR lesions in neuropsychiatrc lupus erythematosus and multiple sclerosis patients. Riv Neuroradiol 2003; 16: 788-791. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.